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Abstract: Since the declaration of the global pandemic of COVID-19 by the World Health Organization on 24 
March 11, 2020; we have continued to see a steady rise in the number of patients infected by SARS-CoV-2. 25 
However, there is still very limited data on the course and outcomes of this serious infection in a 26 
vulnerable population of pregnant patients and their fetuses. International perinatal societies and 27 
institutions including SMFM, ACOG, RCOG, ISUOG, CDC, CNGOF, ISS/SIEOG and CatSalut have 28 
released guidelines for the care of these patients. We aim to summarize these current guidelines in a 29 
comprehensive review for patients, healthcare workers and healthcare institutions. We included 15 30 
papers from 10 societies through a literature search of direct review of society’s websites and their journal 31 
publications up till April 20, 2020. Recommendations specific to antepartum, intrapartum, and 32 
postpartum were abstracted from the publications and summarized into tables 2, 3 and 4 respectively. 33 
The summary of guidelines for management of COVID-19 in pregnancy across different perinatal 34 
societies is fairly consistent, with some variation in the strength of recommendations. It is important to 35 
recognize that these guidelines are frequently updated, as we continue to learn more about the course and 36 
impact of COVID-19 in pregnancy. 37 
Keywords: 1) Coronavirus 2) COVID-19 3) Pandemic 4) SARS-CoV-2; 5) Pregnancy; 6) Guidelines 7) 38 
Prevention 8) Screening 9) Perinatal 39 
 40 
1. Introduction 41 
The World Health Organization (WHO) declared a global pandemic of COVID-19, caused by 42 
SARS-CoV-2 on March 11, 2020 1. The rapidly escalating numbers of individuals infected globally remain 43 
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on the rise and little is still known about the course and outcomes of this serious infection in a vulnerable 44 
population of pregnant patients and their fetuses.  45 
A variety of professional societies and institutions involved in the care of pregnant patients including 46 
Society for Maternal and Fetal Medicine (SMFM)2, 3 from United States, American College of Obstetrics and 47 
Gynecology (ACOG)4, 5 from United States, Royal College of Obstetrics and Gynecology (RCOG)6 from 48 
United Kingdom, International Society for Ultrasound in Obstetrics and Gynecology (ISUOG)7, United 49 
States Centers of disease control (CDC)[8, 9], the World Health Organization (WHO)8, College National de 50 
Gynecologie et Obstetrique Francais (CNGOF)9 from France, Società Italiana di Ecografia Ostetrico 51 
Ginecologica /Istituto Superiore Sanità (SIEOG/ISS)10 from Italy and the Catalan Health Service (CatSalut) 52 
11from Spain have released independent guidelines for the assessment and care of pregnant patients from 53 
prenatal course to intrapartum to postpartum.  54 
A paper published by Boelig et al in March 2020 3to guide Maternal Fetal Medicine specialists on the 55 
care of SARS-Cov-2 pregnant patients, urged healthcare providers and their institution to develop internal 56 
guidelines to have their unit ready to care for these patients .   57 
In order to help institutions keep up with this rapidly evolving landscape; the authors of this paper 58 
aim to summarize and discuss all the current guidelines put forth by the aforementioned professional 59 
societies and institutions into one document. The goal is to allow institutions access to a comprehensive 60 
summary of guidelines related to the SARS-Cov-2 pandemic in pregnancies; which they can adapt to their 61 
practice environment and capabilities. The primary focus of all published guidelines is to design a model 62 
where patients and their families, as well as healthcare workers (HCW) in the frontline of the pandemic are 63 
protected and prepared. 64 
2. Experimental Section 65 
Perinatal guidelines that are frequently cited in the United States include publications by SMFM, 66 
ACOG and ISUOG. However, to encompass a global picture and include guidelines that can be 67 
generalized to a larger patient population; we included some international guidelines from five countries 68 
(US, UK, Italy, Spain and France). These were selected based our collaboration with the co-authors from 69 
the respective countries to help with translation of documents or clinical application relevance- these 70 
societies include RCOG from United Kingdom, CNGOF from France, CatSalut from Spain, and SIEOG/ISS 71 
from Italy. Publications from outside of United States were selected by authors affiliated with that country 72 
respectively. We also included WHO and CDC for their expertise in global health care and infectious 73 
diseases respectively.  74 
A literature search was performed through direct review of all the aforementioned society’s website 75 
and journal publications, and PubMed. Guidelines published between December 2019 and April 20, 2020- 76 
with selection of the most updated versions were included. The search plan for SMFM, ACOG and RCOG 77 
were arranged and done by two authors K.N. and E.I. with input from the study's principal 78 
investigator-R.R. RCOG publication was reviewed by author M.K. from UK, CNFOG was reviewed, 79 
selected and translated by author O.P., CatSalut publication was reviewed, selected and translated by 80 
authors R.E., A.S., E.C. from Spain, and ISS/ SEIOG was reviewed, selected and translated by author G.T. 81 
from Italy- all applying the Preferred Reporting Items for Systematic Reviews and Meta Analyses 82 
(PRISMA) guidelines for the data extraction and quality assessment. Keywords used to search include- 83 
COVID-19 and/or SARS-CoV-2 infection in pregnancy- and name of society. Publications were included if 84 
they are an original document from the society, if they outline details on management of patients either 85 
during antepartum, intrapartum or postpartum, and if they were expert opinions or expert guidance. 86 
Exclusion criteria include case series, case reports, retrospective cohort studies, systematic reviews or 87 
metaanalysis. ACOG, SMFM, ISS and CDC had two publications relevant to guidance for perinatal care 88 
and were all included. All other societies had one publication each. A total of 15 papers were identified 89 
from 10 societies and reviewed by two authors (K.N. and E.I.) who were in agreement. The list of 90 
publications included are summarized in (Table 1), arranged in ascending order of publication date.   91 
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All the publications were thoroughly reviewed and important points of discussions were abstracted 92 
and summarized into - antepartum, intrapartum and postpartum management, discussed in the next 93 
section. Not all publications addressed every aspect of cares; but we summarized the most salient points in 94 
each publication in order to highlight the similarities and differences amongst these international 95 
guidelines. 96 
Table 1. Sources of Evidence. 97 
Journal/ Website Professional Society/ Institution Publication Title Publication Date 
ISS website 
https://www.iss.it/coronavirus 
 
Superior Institute of Health 
 
Educational course on Health 
Emergency on novel 
Coronavirus 
February28, 2020 
 
UOG Journal 
https://obgyn.onlinelibrary.wil
ey.com/doi/10.1002/uog.22013 
 
ISUOG (International Society) 
ISUOG Interim Guidance on 
2019 novel coronavirus 
infection during pregnancy 
and puerperium: information 
for healthcare professionals 
March 12, 2020 
ACOG website 
https://www.acog.org/clinical/
clinical-guidance/practice-advi
sory/articles/2020/03/novel-cor
onavirus-2019 
 
ACOG (United States) 
Novel Coronavirus 2019- 
Practice advisory 
March 13, 2020 
CDC website  
https://www.cdc.gov/coronavi
rus/2019-ncov/hcp/index.html 
 
CDC (United States) 
Information for Healthcare 
Providers: COVID-19 and 
Pregnant women 
March 16, 2020 
WHO website 
https://www.who.int/reprodu
ctivehealth/publications/mater
nal_perinatal_health/anc-posit
ive-pregnancy-experience/en/ 
 
WHO (International Society) 
Q&A on COVID-19, 
pregnancy, childbirth and 
breastfeeding 
March 18, 2020 
AJOG-MFM Journal 
https://www.sciencedirect.co
m/science/article/pii/S2589933
320300367 
 
SMFM (United States) MFM Guidance for COVID-19 March 19, 2020 
CNGOF 
https://pubmed.ncbi.nlm.nih.g
ov/32199996/ 
CNGOF (France) 
SARS-CoV-2 infection during 
pregnancy. Information and 
proposal of management care. 
CNGOF 
March 19, 2020 
CatSalut Website 
https://canalsalut.gencat.cat/w
eb/.content/_A-Z/C/coronavir
us-2019-ncov/material-divulga
tiu/guia-actuacio-embarassade
s.pdf. 
CatSalut (Barcelona) 
SARS-CoV-2 coronavirus 
infection 
Information for pregnant 
women and their families. 
March 20, 2020 
ACOG website 
https://www.acog.org/clinical-
information/physician-faqs/co
vid-19-faqs-for-ob-gyns-obstet
rics 
 
ACOG (United States) 
COVID-19 FAQs for 
Obstetrician-Gynecologists, 
Obstetrics 
March 23,2020 
AJOG-MFM Journal 
https://www.sciencedirect.co
m/science/article/pii/S2589933
320300409 
 
SMFM (United States) 
Labor and Delivery Guidance 
for COVID-19 
March 25, 2020 
ISS website 
https://www.iss.it/coronavirus 
Superior Institute of Health 
(Italy) 
Rational use of individual 
protection devices in the 
March 28, 2020 
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 assistance of Covid-19 patients 
SIEOG website  
https://obgyn.onlinelibrary.wil
ey.com/doi/abs/10.1002/ijgo.13
162?af=R 
 
Italian Society for Ultrasound 
in Obstetrics and Gynecology 
(Italy) 
SARS-Cov-2 Pandemic: 
Information and 
Recommendation 
March 29,2020 
CDC website  
https://www.cdc.gov/coronavi
rus/2019-ncov/need-extra-prec
autions/pregnancy-breastfeedi
ng.html 
 
CDC (United States)  
COVID-19: Pregnancy and 
breastfeeding 
April 3,2020 
CatSalut Website 
https://canalsalut.gencat.cat/w
eb/.content/_A-Z/C/coronavir
us-2019-ncov/material-divulga
tiu/guia-actuacio-embarassade
s.pdf. 
 
CatSalut (Barcelona) 
Clinical guideline for new 
cases of SARS-CoV-2 
coronavirus infection in 
pregnant women and infants   
April 6, 2020 
RCOG Journal  
https://www.rcog.org.uk/glob
alassets/documents/guidelines
/2020-04-17-coronavirus-covid
-19-infection-in-pregnancy.pdf 
 
RCOG (United Kingdom) 
COVID- 19 infection in 
pregnancy 
April 17, 2020 
3. Results 98 
After reviewing all the publications, information was classified into antepartum, intrapartum or 99 
postpartum management and is summarized in a systematic fashion into tables 2, 3 and 4 respectively. 100 
• Prenatal and antepartum care (See Table 2): all guidelines support some form of screening of 101 
pregnant patients depending on symptoms and exposure, use of telehealth is encouraged for 102 
prenatal visits, while limiting face to face visits and ultrasounds only to those that are medically 103 
necessary. Prenatal appointments, lab work and ultrasounds should be scheduled on the same day 104 
if possible. All ultrasound equipment and patient rooms should be appropriately cleaned after 105 
each use. The use of antenatal corticosteroids for fetal lung maturation can be continued till 34 106 
weeks gestation, but the use of steroids in the late preterm period, > 34 0/7 weeks gestation remains 107 
controversial.  108 
• Intrapartum care (See Table 3): all guidelines recommend a designated area within the unit to care 109 
for COVID-19 positive pregnant patients or Person under investigation (PUI). Timing and mode of 110 
delivery should follow routine obstetric indications. Cesarean delivery (CD) should be reserved for 111 
obstetric indications only; infection with COVID-19 is not an indication for cesarean delivery 112 
unless there is acute decompensation of mother or fetus. Only one consistent asymptomatic 113 
support person is allowed to be present at time of delivery. Patients and healthcare workers should 114 
be appropriately gowned, gloved and have protective face masks; specifically N95 should be used 115 
for aerosol generating procedures such as forceful expiration during pushing, use of oxygen for 116 
intrauterine resuscitation or intubation. Use of operative delivery to shorten second stage of labor 117 
can be considered for routine obstetric indications. There is no contraindication to regional or 118 
general anesthesia if indicated; but appropriate personal protective equipment (PPE) use is 119 
encouraged. 120 
• Postpartum care (See Table 4): all guidelines encourage early discharge from the hospital, 1 day for 121 
vaginal delivery and 2 days for cesarean delivery. This limits face to face exposure and increases 122 
bed availability. Separation of mother and baby or discouraging breastfeeding are not advised, 123 
unless the mother is acutely ill. However, mothers are encouraged to 1) Practice respiratory 124 
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hygiene during feeding, 2) wear a mask, 3) wash hands before and after touching the baby and, 4) 125 
routinely clean and disinfect surfaces they have touched. If breastpumping is used, all equipments 126 
should be cleaned thoroughly before and after each use. Postpartum visits should be performed 127 
over telehealth, unless face to face visit is essential to management. 128 
 129 
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Table 2. Summary of guidelines for antepartum care of pregnant patients during COVID-19 pandemic. 130 
TITLE Professional Society ISUOG CNGOF ACOG SMFM RCOG WHO CDC CatSalut  SIEOG/ISS 
PRENATAL 
CARE AND 
ANTEPARTUM 
Infection 
Screening 
 
-Set up 
triage 
screening 
area 
 
-All 
outpatients 
should be 
assessed 
and 
screened for 
TOCC and 
symptoms  
 
-All HCW 
should wear 
appropriate 
PPE 
 
-All 
suspected 
cases should 
be screened 
with 
qRT-PCR 
 
-Repeat 
testing in 24 
hours if 
negative, 
but still 
high 
suspicion  
 
-Chest CT 
should be 
considered, 
if high 
-Set up triage 
screening area 
-Patients should 
be provided with a 
surgical mask at 
the entrance (and 
is not to be 
removed until the 
patient is isolated 
in a suitable room) 
 
-All outpatients 
should be assessed 
and screened for 
TOCC and 
symptoms  
 
-All HCW should 
wear appropriate 
PPE 
 
-All suspected 
cases should be 
screened with 
qRT-PCR 
-Symptomatic 
patients should be 
treated as positive 
till results are back 
Patients with 
suspected 
COVID-19 who 
present with 
obstetric 
emergency should 
be transferred 
immediately to an 
isolation room by 
-Routine screening 
before appointment, 
if suspicious.  
 
-If symptomatic, 
initiate testing and 
notify health 
department, mark 
patient as PUI 
 
-Screening algorithm 
https://www.acog.or
g/-/media/project/aco
g/acogorg/files/pdfs/
clinical-guidance/pra
ctice-advisory/covid-
19-algorithm.pdf  
 
-All HCW should 
wear PPE (Face 
mask, Eye protection, 
gloves  and gown) 
-Triage 
symptomatic 
patients via 
telehealth 
 
-Test anyone 
with new flu like 
symptoms, 
especially older, 
immune-compro
mised, advanced 
HIV, homeless, 
hemodialysis. 
 
-Utilize drive 
through or 
standalone 
testing area 
 
-Symptomatic 
patients should 
be treated as 
positive till 
results are back 
-Patients 
should be 
provided with 
a surgical mask 
at the entrance 
(and is not to be 
removed until 
the patient is 
isolated in a 
suitable room) 
 
 -Screen all 
patients 
presenting to 
maternity unit. 
 
-Patients who 
meet criteria 
(see guideline 
for details) for 
potential 
COVID-19shou
ld have a full 
blood count 
evaluation; if 
lymphopenia is 
identified, 
COVID-19 
testing should 
be arranged. 
 
-Patients with 
suspected 
COVID-19 who 
present with 
obstetric 
emergency 
should be 
-Testing 
protocols and 
eligibility vary 
depending on 
where you live. 
  
-Symptomatic 
and high risk 
patients should 
get screening 
priority 
 
-HCW should 
maintain hand 
hygiene, and 
appropriate use 
of protective 
clothing like 
gloves, gown 
and medical 
mask. 
- Same as 
general 
population 
-Women are 
asked to 
phone prior 
to antenatal 
visit. All 
women 
should take 
preventive 
measures 
when 
attending 
health care 
settings    
 
 
-Screen 
women with 
symptoms 
presenting to 
antenatal 
clinic 
 
 
-Symptomati
c patients 
should be 
treated as 
positive till 
negative 
results are 
back 
 
 
 
 
 
 
 
Telephone triage. 
Screen  with 
symptoms 
Asymptomatic 
mothers: respect 
hygiene measures, 
social distancing .  
PPE not required 
 
Symptomatic 
mothers: 
individual PPE 
required for 
mothers and HCW 
 
Symptomatic 
mothers are tested 
for CoV-2 using 
nasopharyngeal 
swabs and 
isolation in a 
dedicated room. 
Public Hygiene 
Service be 
informed. 
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suspicion  HCW using 
appropriate PPE. 
Obstetric 
management 
should not be 
delayed for 
COVID-19 testing 
transferred 
immediately to 
an isolation 
room by HCW 
using 
appropriate 
PPE. Obstetric 
management 
should not be 
delayed for 
COVID-19 
testing 
 
-Symptomatic 
patients should 
be treated as 
positive till 
results are back 
Place of care 
-Negative 
pressure or 
single 
isolation 
rooms in 
tertiary care 
center 
 
-ICU for 
critical 
patients 
-Isolation room for 
patients with 
suspected/confirm
ed COVID-19 for 
whom care cannot 
be safely delayed 
for self-isolation 
-N/A 
-Designated 
COVID-19 area 
within the 
facility 
-Isolation room 
for patients 
with 
suspected/confi
rmed 
COVID-19 for 
whom care 
cannot be 
safely delayed 
for 
self-isolation 
-N/A 
Same as 
general 
population 
Same as 
general 
population.  
If hospital 
admission is 
needed, 
women are 
referred to 
one reference 
hospital in 
the Region 
Asymptomatic: 
delivery at General 
Hospitals 
 
Stable 
symptomatic 
mothers delivery 
at General hospital 
with designated 
area within the 
facility. Delivery in 
isolated room. 
Mothers, medical 
staff and a single 
accompanying 
person must wear 
PPE. Room 
ventilation at least 
with 60 L/s. 
Mothers & babies 
are kept in isolated 
room 
 
 
-Unstable 
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symptomatic 
mothers delivery 
attertiary care 
center with ICU 
facilities 
Prenatal 
appointmen
t 
-Postpone 
by 14 days if 
positive or 
until 2 
negative 
results 
Elective and 
non-urgent 
appointments 
should be 
postponed or 
completed by 
telehealth 
 
-Encourage use of 
telehealth for all 
visits -HCW 
meetings should 
all be 
virtual/audio. 
Keep some 
providers at home 
 
-No support 
persona at 
outpatient visit 
 
 
-If, after screening, 
the patient reports 
symptoms of or 
exposure to a person 
with COVID-19, that 
patient should be 
instructed not to 
come to the health 
care facility for their 
appointment and 
health care clinicians 
should contact the 
local or state health 
department to report 
the patient as a 
possible person 
under investigation 
(PUI) 
- Elective and 
non-urgent 
appointments 
should be 
postponed or 
completed by 
telehealth 
 
-Encourage use 
of telehealth for 
all visits  
 
 
-HCW meetings 
should all be 
virtual/audio. 
Keep some 
providers at 
home 
 
-No support 
persona at 
outpatient visit 
 
-Labs and US at 
the same 
appointment 
 
-Provide patient 
with ambulatory 
BP cuff/machine 
 
-F2F visits at 
11-13,20,28,36 
weeks and 
weekly after 37 
weeks 
-Routine 
appointments 
for women 
with 
suspected/confi
rmed COVID 
19 should be 
delayed until 
after the 
recommender 
period of 
self-isolation. 
 
-For 
symptomatic 
patients, defer 
appointments 
until 7 days 
after symptom 
onset; defer 
appointments 
for 14 days for 
patients with 
symptomatic 
household 
contacts 
 
Encourage the 
use of 
telephone for 
non-urgent 
consultation/en
quiries  
 
-N/A N/A 
Encourage 
use of 
telehealth for 
all visits  
 
-Routine antenatal 
care appointment 
monthly for 
asymptomatic 
mothers. Planned 
visit @ at maternity 
unit at 37-38 weeks 
and then at 40 
weeks, if 
physiologic 
pregnancy. 
 
-Symptomatic 
mothers: delay 
appointments for 
several days 
according to 
symptoms, 
recommend GP 
consultation and 
keep telephone 
contacts 
Ultrasound  -Suspected, -Continue US as -Continue US as -Combine dating -In addition to -N/A N/A Continue US -Asymptomatic 
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frequency asymptomat
ic confirmed 
and 
recovering 
patients: US 
q 2-4 weeks 
for Fetal 
growth and 
AFI, UA 
dopplers if 
indicated 
medically 
indicated when 
possible.  
 
medically indicated 
when possible.  
 
-Elective US should 
not be performed. 
  
- Postpone or cancel 
testing or 
examinations if the 
risk of exposure and 
infection within the 
community 
outweighs the 
benefit of testing. 
 
 
and NT in 1st 
trimester 
 
-Anatomy scan 
at 20-22weeks 
 
- Consider 
stopping serial 
CL after 
anatomy 
US if TVUS CL 
≥35mm, prior 
preterm birth at 
>34 
weeks 
 
-BMI>40: 
schedule at 22 
weeks to reduce 
risk of 
suboptimal 
views/need for 
follow up 
 
-Single growth 
F/U at 32 weeks 
 
-Low lying 
placenta F/U 
34-36wks 
 
-Refer to 
primary 
publication for 
disease specific 
US frequency 
routine 
ultrasound 
surveillance, 
fetal growth 
restriction 
surveillance is 
recommended 
14 days after 
resolution of 
acute illness 
due to 
theoretical risk 
of growth 
restriction.  
as medically 
indicated 
when 
possible 
 
mothers: continue 
US assessment as 
routine 
 
 
-Symptomatic 
mothers: following 
14 days of 
isolations and 
resolution of 
symptoms, general 
clinical 
examination and 
ultrasound 
assessment for 
fetal growth every 
3-4 weeks 
 
Ultrasound 
Equipment/ 
patient 
rooms 
-Must be 
cleaned 
with 
disinfectant 
per 
manufactur
er 
Must be cleaned 
with disinfectant 
per manufacturer 
guidelines after 
EVERY use 
N/A 
-Wipe down 
patient rooms 
after every visit 
of suspected 
COVID patients 
-Decontaminat
e after use on 
suspected or 
confirmed 
COVID 
patients 
-N/A N/A 
Deep clean of 
all 
instruments 
and room in 
case of 
positive 
patient 
Deep clean of all 
instruments and 
room ventilation 
every 10 minutes 
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guidelines 
after EVERY 
use 
 
-Deep clean 
of all 
instruments 
and room in 
case of 
positive 
patient 
 
 
Antenatal 
corticosteroi
ds 
(BMZ) 
-Avoid in 
critically ill 
patient; risk 
of 
worsening 
disease 
- Should continue 
if <34 weeks, even 
if tested positive 
for SARS-CoV-2 
 
- Should continue if 
<34 weeks, even if 
tested positive for 
COVID-19 
 
- Controversial for 34 
0/7–36 6/7 Weeks  
 
-Other modifications 
should be 
individualized 
-Judicious use 
<34 weeks 
 
-Avoid >34 
weeks 
-Administer for 
routine 
indications 
 
-No evidence to 
suggest harm 
in the context 
of SARS-CoV-2 
infection  
-N/A N/A 
Administer 
for routine 
indications 
 
N/A 
GBS 
screening 
-Delay by 
14days in 
patients 
with TOCC 
risk factors 
- As indicated 
between, 36 0/7–37 
6/7 weeks 
gestation. 
 
- As indicated 
between, 36 0/7–37 
6/7 weeks gestation. 
 
-Patients can 
self-collect with 
proper instructions if 
the resources and 
infrastructure allow 
-Routine 
screening at 
36wks 
N/A -N/A N/A 
Routine 
screening  
 
Routine screening 
 
Antenatal 
surveillance 
(BPP, NST) 
-N/A 
Daily NST if 
patient 
hospitalized 
- Reserve for 
medically indicated 
screening 
 
-During acute illness, 
fetal management 
should be similar to 
that provided to any 
ill pregnant person.  
 
-Limit NSTs if 
<32 wks 
 
-Twice weekly 
NST only for 
FGR with 
abnormal UA 
Doppler studies 
 
-If patient needs 
US, perform BPP 
instead of NST 
N/A -N/A N/A N/A N/A 
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-Kick counts 
instead of NST 
for low risk 
patients 
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*Legend- (Travel history, occupation, significant contact and cluster (TOCC)), Healthcare worker (HCW), Personal protective equipment (PPE), Face to face (F2F)  132 
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Table 3. Summary of guidelines for intrapartum care of pregnant patients during COVID-19 pandemic. 133 
TITLE Professional Society ISUOG CNGOF ACOG SMFM RCOG WHO CDC CatSalut SEIOG/ISS 
INTRAPARTUM 
CARE 
 
 
Pre-Delivery 
preparation 
-Social 
distancing 
-Social 
distancing 
-Obstetric, 
pediatric or 
family medicine, 
and anesthesia 
teams should be 
notified in order 
to facilitate care. 
-Social distancing 
and off work for 2 
weeks prior to 
anticipated 
delivery (start at 
~37wks) 
 
-Screen patient 
and partner on 
phone day before 
admission 
 
-Institution 
should run 
simulations  
-Minimum staffing 
and social distancing  
 
-Screen patient and 
partner at maternity 
unit. Partners with 
symptoms less than 
7 days prior should 
be instructed to 
self-isolate and not 
be allowed into the 
maternity unit. 
Women with 
suspected or 
confirmed 
COVID-19 should be 
encouraged to 
remain at  home  
during early labor; 
women in active 
labor should be 
admitted to an 
isolation room 
 
-Dry run simulations 
for 
elective/emergency 
procedures 
 
 
-If 
COVID-19 
is 
suspected 
or 
confirmed, 
health 
workers 
should take 
all 
appropriate 
precautions 
to reduce 
risks of 
infection to 
themselves 
and others, 
including 
hand 
hygiene, 
and 
appropriate 
use of 
protective 
clothing 
like gloves, 
gown and 
medical 
mask. 
N/A 
Screen women 
with symptoms 
at maternity unit 
Respectful care 
must be always 
considered 
minimum 
number of 
professionals 
attending 
women. Only 
one partner 
allowed for 
companionship 
during labor and 
delivery.  
 
Screen women 
with symptoms at 
maternity unit 
 
Asymptomatic: as 
per routine care.  
 
-Stable 
Symptomatic 
patients- admit to 
hospital 
 
-Unstable 
symptomatic 
patients: refer to 
hospitals with ICU 
facility 
Delivery Time 
-Based on 
routine 
obstetric 
indications 
-Early 
delivery 
should be 
considered 
for critically 
-If infection 
in early 
pregnancy 
with 
recovery, No 
alterations in 
delivery 
time. 
-Based on 
-If infection in 
early pregnancy 
with recovery, No 
alterations in 
delivery time. 
-If infection in 
late pregnancy 
and recovery, 
postpone 
-Based on routine 
indications 
 
-No 
contraindication 
to induction of 
labor unless beds 
are limited 
 
-Based on routine 
indications 
-N/A N/A 
-PPE in all cases. 
 
-Continuous 
fetal electronic 
monitoring. 
-Per routine 
Obstetric 
indications 
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ill patients routine 
obstetric 
indications 
-Early 
delivery 
should be 
considered 
for critically 
ill patients 
delivery (if no 
other medical 
indications arise) 
until a negative 
testing result is 
obtained or 
quarantine status 
is lifted in an 
attempt to avoid 
transmission to 
the neonate. 
-COVID-19 is not 
an indication of 
delivery. 
-For term 
COVID-19 
patients, consider 
delivery because 
symptoms peak 
in 1-2 weeks after 
onset 
Delivery location 
-Designated 
negative 
pressure 
isolation 
room 
-Designated 
isolation 
room, for 
suspected or 
confirmed 
cases of 
COVID-19 
-N/A 
-Designated 
delivery and 
operating rooms 
-Designated 
isolation room, for 
suspected or 
confirmed cases  
-N/A N/A 
-Designed 
isolation room 
for suspected or 
confirmed cases 
of COVID-19.   
 
-Designed 
negative 
pressure 
isolation room 
for CD 
Designated 
isolated room for 
suspected or 
confirmed cases 
Mode of Delivery 
-Based on 
routine 
obstetric 
indications 
-Infection is 
NOT an 
indication 
for CD 
 
-Expedite 
delivery by 
CD in 
setting of 
fetal distress 
or maternal 
deterioration 
  
-Water birth 
-Based on 
routine 
obstetric 
indications 
-Infection is 
NOT an 
indication 
for CD 
 
-Expedite 
delivery by 
CD in 
setting of 
fetal distress 
or maternal 
deterioration 
-Per routine 
obstetric 
indications. 
 
-No specific 
recommendations 
for CD 
 
-Operative 
vaginal delivery 
is not indicated 
for suspected or 
confirmed cases  
alone, but can be 
used as routinely 
indicated 
-Based on routine 
obstetric 
indications 
 
-Infection is NOT 
an indication for 
CD 
 
-Based on routine 
obstetric indications 
unless maternal 
respiratory 
condition demands 
early delivery. 
 
-Water birth should 
be avoided.   
-As 
clinically 
indicated 
N/A 
-Based on 
routine obstetric 
indications  
 
-Infection is not 
an indication for 
CD 
Routine obstetric 
indications 
 
Infection is not an 
indication for CD 
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should be 
avoided 
Support person 
-Limit 
visitors, no 
clear 
number 
specified 
No visitor 
- Allowed one 
consistent 
asymptomatic 
support person 
-Allowed one 
consistent 
support person  
 
-No children 
<16-18y/o 
-Allowed one 
consistent 
asymptomatic 
support person who 
should be restricted 
to the patient’s 
bedside.  
-N/A N/A 
-Companionship 
by one person 
relative to the 
women is 
encouraged 
during all the 
labor and 
delivery 
 
 
-Single 
accompanying 
asymptomatic 
person 
Obstetric 
Analgesia and 
Anesthesia 
-Regional 
and General 
anesthesiaca
n be 
considered 
-Regional 
and General 
anesthesia 
can be 
considered 
N/A 
-Avoid use of 
nitrous oxide 
-NO evidence 
against regional or 
general anesthesia.  
 
-Epidural analgesia 
is recommended 
insuspected or 
confirmed cases, to 
minimize the need 
for GA if urgent 
delivery is needed.  
-N/A N/A 
-Epidural 
analgesia is 
recommended to 
women with 
suspected or 
confirmed 
COVID-19 to 
minimize the 
need for GA if 
urgent delivery 
is needed.  
 
 
-Regional and 
General anesthesia 
can be considered 
Second Stage of 
Labor 
-Consider 
shortening 
with 
operative 
delivery to 
minimize 
aerolization 
and 
maternal 
respiratory 
effort 
N/A N/A 
-Do not delay 
pushing 
 
-Considered 
aerolizing, N95 
should be worn 
by HCW and 
patients 
-Consider 
shortening with 
operative vaginal 
delivery in 
symptomatic 
women who become 
exhausted or 
hypoxic  
-N/A N/A N/A N/A 
Third stage of 
Labor  N/A N/A 
-Active 
management to 
reduce blood loss 
(national blood 
shortage) 
N/A -N/A N/A 
-Active 
management in 
all cases 
-Per routine 
Oxygen 
supplementation  N/A N/A N/A 
-Considered 
aerolizing, HCW 
-Hourly O2 sat 
measurements (in 
N/A N/A N/A N/A 
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must wear 
appropriate PPE 
 
-Do not use O2 
for intrauterine 
resuscitation 
addition to routine 
maternal-fetal 
observations) for 
women with 
suspected/confirmed 
COVID-19. 
 
-Aim to keep o2 sat 
>94%, titrating o2 
therapy accordingly.  
Umbilical cord 
clamping 
-Avoid 
delayed cord 
clamping in 
confirmed 
and 
suspected 
cases 
N/A 
-No 
recommendations 
against delayed 
clamping of 
Umbilical cord. 
-Avoid delayed 
cord clamping 
-Delayed cord 
clamping is still 
recommended in the 
absence of 
contraindications 
-N/A N/A 
Delayed cord 
clamping is still 
recommended in 
the absence of 
contraindications 
-General rule 
PPE use  N/A -N/A 
-Asymptomatic 
or negative 
patients- Patient 
and provider 
wear surgical 
mask  
 
-Aerolizing 
procedures-N95 
for patient and 
N95,gown,gloves, 
face shield for 
provider 
-Level of PPE should 
be based on the risk 
of requiring GA. 
 
-Aerosolizing 
procedures-use FFP3 
mask 
-N/A 
Same as 
general 
population 
N/A 
-Symptomatic 
with stable or 
unstable 
condition: 
Mothers, medical 
staff and 
accompanying 
person must wear 
all protection 
devices. Masks 
should be 
FFP2/FFP3 type. 
Elective Cesarean 
delivery/induction 
of labor (IOL)  
 N/A N/A 
-No 
contraindication 
to IOL unless 
there is limited 
beds 
 
-For 
suspected/confirmed 
cases, consider delay 
of elective CD or 
IOL if safely feasible 
to  
  
N/A N/A N/A N/A 
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TITLE Professional Society ISUOG CNOGF ACOG SMFM RCOG WHO CDC CatSalut  SIEOG/ISS 
POSTPART
UM CARE 
 
 
Placental or 
fetal tissue 
-Should be 
handled as 
infectious 
tissue in 
positive 
patients 
-Consider 
qRT-PCR on 
placenta 
N/A N/A -N/A N/A -N/A N/A N/A N/A 
Length of 
stay -N/A N/A 
-Expedited 
discharge 
should be 
considered. 
-VD   1 day 
-CD 2 days 
-Expedited 
discharge 
should be 
considered. 
-VD   1 
day 
-CD 2 days 
N/A -N/A 
Same as 
general 
population 
Expedited 
discharge 
should be 
considered 
 
 
Asymptomatic→
2 days 
Symptomatic→ 3 
days 
Breastfeeding 
-Insufficient 
evidence 
-Okay for 
asymptomatic 
patients, 
mothers should 
use masks and 
wash hands 
-Separation 
and breast 
pumping 
suggested in 
critically ill 
patients 
Limited 
evidence to 
advice against 
breastfeeding.  
 
-Advise 
patients to: 
wash hands 
before 
handling 
baby, 
touching 
pumps or 
bottle; avoid 
coughing 
while baby is 
feeding; 
consider 
wearing face 
mask while 
feeding or 
handling 
baby;  
 
-N/A 
-Advise 
patients to: 
wash hands 
before 
handling 
baby, 
touching 
pumps or 
bottle; avoid 
coughing 
while baby is 
feeding; 
consider 
wearing face 
mask while 
feeding or 
handling 
baby; if breast 
pump us 
used, clean 
properly after 
each use; 
consider 
asking 
someone who 
-No 
contradiction
s 
 
-Advice 
patients to: 
wash hands 
before 
handling 
baby, 
touching 
pumps or 
bottle; avoid 
coughing 
while baby is 
feeding; 
consider 
wearing face 
mask while 
feeding or 
handling 
baby; if 
breast pump 
us used, 
clean 
-Women with 
COVID-19 
can 
breastfeed if 
they wish to 
do so.  
They should: 
1) Practice 
respiratory 
hygiene 
during 
feeding, 2) 
wear a mask  
3) Wash 
hands before 
and after 
touching the 
baby 
4) Routinely 
clean and 
disinfect 
surfaces they 
have touched. 
-During 
separation 
encourage 
dedicated 
breast pump 
 
-Mother 
should use 
facemask and 
practice hand 
hygiene after 
each feeding 
- Encourage 
breastfeeding 
support 
 
1) Practice 
respiratory 
hygiene 
during 
breastfeeding.  
2) wear a mask  
3) hands and 
tissues hygiene 
before and 
after 
breastfeeding 
- Encourage 
breastfeeding 
support 
 
Symptomatic: 
 1) hands and 
tissue hygiene 
 
2) wear a surgical 
mask 
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is well to feed 
baby.  
 
properly 
after each 
use; consider 
asking 
someone 
who is well 
to feed baby.  
 
Skin to skin 
-Can be 
considered 
with 
appropriate 
PPE use for 
asymptomatic 
patients 
N/A -N/A -N/A 
-Routine 
precautionar
y separation 
of a healthy 
baby and 
mother is not 
advised at 
this point.  
- Allow with 
precautions 
and good 
hygiene 
clean. 
N/A 
-Individualize 
according to 
the conditions 
of the mother 
and the baby 
 
N/A 
-Postpartum 
pain control -N/A N/A -N/A 
-No 
contraindicati
on to NSAID 
use 
N/A N/A N/A -N/A N/A 
 
Postpartum 
visit -N/A 
Encourage 
telehealth for 
postpartum 
visit 
-Encourage 
telehealth for 
postpartum 
visit. 
 
-Delay 
comprehensive 
face to face 
postpartum 
visit to 12 
weeks 
 
- Use telehealth 
before 12 
weeks.-  
 
-Encourage 
telehealth for 
postpartum 
visit 
-Encourage 
telehealth for 
postpartum 
visit  
 
 
N/A N/A 
-Stay at home 
policy and 
encourage of 
telehealth 
postpartum 
visits 
home visit by 
health 
professional 
(midwife) 
between 48-72 
hours after 
discharge 
N/A 
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4. Discussion 136 
The overall summary of guidelines for management of COVID-19 in pregnancy across different 137 
professional societies and institutions is consistent; with some variation in the strength of 138 
recommendations. Global societies such as WHO and CDC have a similar approach to their 139 
guideline publication; keeping their recommendations broad so it can be utilized across all shapes 140 
and sizes of healthcare institutions. Many of their recommendations overlap with those for the 141 
general population and they provide great resources to guide readers to perinatal societies for more 142 
specific questions.   143 
International perinatal societies including ACOG, RCOG, SMFM, ISUOG, CNGOF, ISS/SIEOG 144 
and public institution CatSalut, all share similar recommendations answering questions that are 145 
very specific to the care of pregnant patients- from prenatal screening, antepartum care, details of 146 
intrapartum care during different stages of labor in emergency and non-emergency settings, to 147 
postpartum care and follow up. The guidelines put forth by SMFM (United States) are most specific 148 
to the care of high risk pregnancies; given their expertise in this field. ACOG (United States) and 149 
RCOG (United Kingdom) summarize recommendations that are suitable for lower risk pregnant 150 
patients. CNGOF (France) and ISS/SIEOG (Italy) and CatSalut (Barcelona), give some practical 151 
recommendation for the management of infected pregnant women. ISUOG (International) provides 152 
more information specific to managing and cleaning ultrasound equipment--an essential tool in the 153 
care of pregnant patients which could be a vector for disease transmission if sanitization is not a 154 
priority. 155 
The consensus amongst the all perinatal societies encourages all institutions to transition to 156 
telehealth when appropriate and limit the number of face to face visits. Ultrasounds and antenatal 157 
surveillance should be performed only if medically indicated. The use of antenatal steroids for fetal 158 
lung maturation for patient at high risk of preterm birth within 7 days should still be performed if 159 
pregnancy is between 24 0/7 to 33 6/7 weeks gestation; but use during late preterm of 34 0/7 to 36 6/7 160 
weeks gestation is still controversial.  All institutions should set up a designated screening area, 161 
labor and delivery rooms, and operating rooms for SARS-CoV-2 infected patients. All patients 162 
should be screened for symptoms, travel history, contact history and follow the appropriate 163 
algorithm provided to guide need for performing real time PCR test. If elective procedures or 164 
induction of labor is scheduled, patients should first be screened and triaged over the phone, 165 
followed by a nasopharyngeal swab for SARS-CoV-2 infection. This screening should be done 166 
within a time frame to allow the test results to return before the scheduled procedure date. For 167 
urgent or emergent obstetric conditions, screening for SARS-CoV-2 should be performed right away, 168 
but procedures should not be delayed for results to return; patients should be treated as a PUI and 169 
managed as presumptive positive.  170 
As the numbers of testing sites and resources have increased over the past few weeks, there 171 
should be consideration for screening every pregnant patient being admitted, regardless of 172 
exposure, history or symptoms.. Societies recommend only one consistent support person to be 173 
present during delivery. Mode and timing of delivery should still be performed on the basis of 174 
routine obstetric indications; delivery should be expedited with cesarean delivery in the event of 175 
maternal deterioration due to severe COVID-19 disease or fetal distress. Aerosol generating 176 
procedures such as use of supplemental oxygen, intubation and forceful pushing should be avoided 177 
to protect everyone in the delivery room. Appropriate PPE should be donned by patients and 178 
healthcare workers during all interactions. N95 should be worn during aerosol generating 179 
procedures.  180 
Currently, there is no definitive evidence to suggest vertical transmission of SARS-CoV-2.As a 181 
result, mother and baby separation and discouraging breastfeeding are not advised unless the 182 
mother is acutely ill.  Mothers who are acutely ill with SARS-CoV-2 infection are advised the option 183 
for breast pumping, and to wash hands before handling baby, touching pumps or bottle, avoid 184 
coughing while baby is feeding, consider wearing face mask while feeding or handling baby. If a 185 
breast pump is used, clean properly after each use, and routinely clean all surfaces that are touched.  186 
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The length of hospital stay should be decreased to 1 day for vaginal delivery and 2 days for cesarean 187 
delivery to limit time of exposure for patients and healthcare workers in the hospital while also 188 
increasing bed capacity. Once discharged, patients are advised to continue social distancing, and 189 
routine postpartum visits can be conducted using telehealth. The method of telehealth should be 190 
individualized based on institution resources and availability. 191 
5. Conclusions 192 
The present manuscript summarizes the guidelines for Obstetrical and perinatal managements 193 
of pregnant women during the SARS-CoV-2 pandemic, which can be an overall reference for 194 
Obstetricians all over the world.  Many similarities are identified amongst these guidelines. All of 195 
the international professional societies and institutions discussed in this paper, including ACOG, 196 
RCOG, SMFM, ISUOG, WHO, CNGOF, ISS/SIEOG, CatSalut  and CDC, continue to work tirelessly 197 
to put forth updated information for the care of pregnant patients and beyond. This manuscript also 198 
provides the summary of the source for continuous updates. It is imperative for readers to continue 199 
to use the most updated guidelines available as we continue to learn more about the impacts of the 200 
SARS-Cov-2 pandemic in pregnancy.  201 
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